Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
1000 participants
OBSERVATIONAL
2024-11-30
2028-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Blood Pressure Monitoring in Hypertensive Populations: Device Testing, Feasibility, Acceptability
NCT05601414
Improving Adherence to Home Blood Pressure Monitoring With Pharmacist Support
NCT04577131
An Interventional Multidisciplinary Approach to Individualize Blood Pressure Treatment
NCT03209154
The Smart Hypertension Control Study
NCT03288142
A Study in the Use of Home Blood Pressure Monitoring and Telephone Follow-up to Control Blood Pressure
NCT00662753
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Withings device users
Active Withings device users having at least 2 years of device data
Questionnaire
Users who consent to the study will receive a questionnaire every 3 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire
Users who consent to the study will receive a questionnaire every 3 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participant living in the United States,
* Participant with data recorded in WITHINGS database,
* Active WITHINGS device users having at least 2 years of data,
* Subject able to read, understand, and provide written informed consent,
* Subject willing and able to participate in the study procedures as described in the consent form,
* Subject able to communicate effectively with and willing to follow instructions from the study staff.
Exclusion Criteria
* Subject who refused to participate in the study,
* Subject who did not reply to the questionnaire,
* Subject who objected to the processing of his or her data after the start of the study.
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Withings
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
de Havenon, MD
Role: PRINCIPAL_INVESTIGATOR
Yale University School of Medicine, Dept of Neurology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale University Medical School, Department of Neurology
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WIQUEST-HTA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.